Sofosbuvir-based regimen is safe and effective for hepatitis C infected patients with stage 4–5 chronic kidney disease: a systematic review and meta-analysis

BACKGROUND: Whether sofosbuvir is suitable for hepatitis C virus (HCV) infected patients with severe renal impairment is inconclusive. This systematic review aims to evaluate the safety and effectiveness of SOF-based regimen in the setting of stage 4 and 5 chronic kidney disease (CKD). METHODS: We c...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Mingshu, Chen, Jun, Fang, Zhixiong, Li, Yi, Lin, Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419462/
https://www.ncbi.nlm.nih.gov/pubmed/30871566
http://dx.doi.org/10.1186/s12985-019-1140-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419462/
https://www.ncbi.nlm.nih.gov/pubmed/30871566
http://dx.doi.org/10.1186/s12985-019-1140-x

Ejemplares similares